Evolva Holding (Switzerland) Today
EVE Stock | CHF 1.33 0.08 5.67% |
PerformanceOK
| Odds Of DistressLow
|
Evolva Holding is selling for under 1.33 as of the 17th of February 2025; that is 5.67% down since the beginning of the trading day. The stock's lowest day price was 1.33. Evolva Holding has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 28th of February 2023 and ending today, the 17th of February 2025. Click here to learn more.
Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally. The company was founded in 2004 and is headquartered in Reinach, Switzerland. The company has 1.11 B outstanding shares. More on Evolva Holding SA
Moving together with Evolva Stock
Moving against Evolva Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Evolva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Evolva Holding's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Evolva Holding or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Evolva Holding SA (EVE) is traded on SIX Swiss Exchange in Switzerland and employs 62 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 90.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evolva Holding's market, we take the total number of its shares issued and multiply it by Evolva Holding's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Evolva Holding SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 1.11 B outstanding shares.
Evolva Holding SA has accumulated about 11 M in cash with (29.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Evolva Holding Probability Of Bankruptcy
Ownership AllocationEvolva Holding holds a total of 1.11 Billion outstanding shares. Roughly 74.31 percent of Evolva Holding outstanding shares are held by general public with 0.66 (percent) owned by insiders and only 25.03 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Evolva Ownership Details
Evolva Holding SA Risk Profiles
Although Evolva Holding's alpha and beta are two of the key measurements used to evaluate Evolva Holding's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 5.13 | |||
Semi Deviation | 5.07 | |||
Standard Deviation | 6.49 | |||
Variance | 42.12 |
Evolva Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Evolva Holding without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
Evolva Holding Corporate Management
Elected by the shareholders, the Evolva Holding's board of directors comprises two types of representatives: Evolva Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolva. The board's role is to monitor Evolva Holding's management team and ensure that shareholders' interests are well served. Evolva Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolva Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oliver MBA | Advisor | Profile | |
Anne Vos | Chief Officer | Profile | |
Christian Wichert | Chief Officer | Profile | |
Fabienne Gschwind | Head HR | Profile | |
Thomas CFA | Head Relations | Profile | |
Kaspar Mueller | Head Protection | Profile | |
Gerhard Lobmaier | Chief Officer | Profile |
Additional Tools for Evolva Stock Analysis
When running Evolva Holding's price analysis, check to measure Evolva Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolva Holding is operating at the current time. Most of Evolva Holding's value examination focuses on studying past and present price action to predict the probability of Evolva Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolva Holding's price. Additionally, you may evaluate how the addition of Evolva Holding to your portfolios can decrease your overall portfolio volatility.